A possible explanation for the contradictory observations of insulin pathway activation in cellular level and animal level is the effects of ginsenoside Rg1 on insulin resistance and glucose uptake, which could be an indirect secondary effect to its anti-obesity function. Here, INS is linked to obesity disorder.